With reference to the share buyback program announced 5 June 2023, Nordhealth AS
("the Company") has reached the buyback program's maxiumum consideration of NOK
4 million as of 30 June. Under the share buyback program the Company purchased
154,013 of its own shares in the period 5 June 2023 to 30 June 2023 at an
average price of NOK 25.9717 per share for a total consideration of NOK
3,999,975.21.

From 23 June 2023 until 30 June 2023, Nordhealth purchased a total of 35,800 own
shares at an average price of NOK 27.0956 per share.

Aggregated overview of transactions per day:

Date                             Aggregate daily       Weighted         Total
                                    volume (# of  average price   transaction
                                         shares)          (NOK)   value (NOK)
23/06/2023                                12,578        28.0549    352,874.53
26/06/2023                                 4,972        27.1079    134,780.48
27/06/2023                                 3,470        27.3050     94,748.35
28/06/2023                                 6,193        26.0840    161,538.21
29/06/2023                                 6,605        26.4164    174,480.32
30/06/2023                                 1,982        26.0345     51,600.38

Previously disclosed buy-backs           118,213        25.6313  3,029,952.94
under the programme (aggregate)
Total purchased under the                154,013        25.9717  3,999,975.21
programme

This information is published in accordance with the requirements in article 5
of the EU Market Abuse Regulation and subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back
programme that have been carried out during the above-mentioned time period is
attached to this report.

For further information, please contact:

Charles Macbain, CEO

charles.macbain@nordhealth.com

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).